Elevated levels of CCL11 have been demonstrated in neuroinflammatory diseases such as MS, psychiatric disorders such as schizophrenia, and neurodegenerative diseases such as PD and AD (106–108). This evidence concerns the gene CCL11 and Alzheimer disease.